The impact of CMV infection on survival in older humans

Current Opinion in Immunology

Volumn 24, Issue 4, 2012, Pages 507-511

  Pawelec, Graham ^a   McElhaney, Janet E ^b   Aiello, Allison E ^c   Derhovanessian, Evelyna ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANTIBODY TITER; BLOOD; CELL COUNT; CELLULAR IMMUNITY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HUMAN; IMMUNE DYSREGULATION; INFECTION SENSITIVITY; LONGEVITY; MEMORY T LYMPHOCYTE; MORTALITY; PHENOTYPE; PREVALENCE; REVIEW; SURVIVAL; T LYMPHOCYTE; VACCINATION;

AGED; AGED, 80 AND OVER; AGING; CELL AGING; CYTOMEGALOVIRUS INFECTIONS; HUMANS; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 84865302673     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.04.002     Document Type: Review

References (45)

1. Grimley Evans J., Franklin Williams T., Lynn Beattie B., Michel J.-P., Wilcock G.K. Oxford Textbook of Geriatric Medicine 2000, Oxford Textbooks.
2. Horiuchi S., Wilmoth J.R. Age patterns of the life table aging rate for major causes of death in Japan, 1951-1990. J Gerontol A 1997, 52:B67-B77.
3. Day M.J. Ageing, immunosenescence and inflammageing in the dog and cat. J Comp Pathol 2010, 142(Suppl. 1):S60-S69.
4. Maue A.C., Yager E.J., Swain S.L., Woodland D.L., Blackman M.A., Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol 2009, 30:301-305.
5. Larbi A., Franceschi C., Mazzatti D., Solana R., Wikby A., Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology 2008, 23:64-74.
6. Hecker M., Qiu D., Marquardt K., Bein G., Hackstein H. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 2004, 86:41-44.
7. Dowd J.B., Aiello A.E., Alley D.E. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect 2009, 137:58-65.
8. Chakravarti A., Kashyap B., Matlani M. Cytomegalovirus infection: an Indian perspective. Indian J Med Microbiol 2009, 27:3-11.
9. Zhu J., Davidson M., Leinonen M., Saikku P., Gaydos C.A., Canos D.A., Gutman K.A., Howard B.V., Epstein S.E. Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN study. Clin Microbiol Infect 2006, 12:118-122.
10. Looney R.J., Falsey A., Campbell D., Torres A., Kolassa J., Brower C., McCann R., Menegus M., McCormick K., Frampton M., et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999, 90:213-219.
11. Chidrawar S., Khan N., Wei W., McLarnon A., Smith N., Nayak L., Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009, 155:423-432.
12. Derhovanessian E., Maier A.B., Beck R., Jahn G., Hahnel K., Slagboom P.E., de Craen A.J., Westendorp R.G., Pawelec G. Hallmark features of immunosenescence are absent in familial longevity. J Immunol 2010, 185:4618-4624.
13. Litjens N.H., de Wit E.A., Betjes M.G. Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Aging 2011, 8:2.
14. Morgan M.D., Pachnio A., Begum J., Roberts D., Rasmussen N., Neil D.A., Bajema I., Savage C.O., Moss P.A., Harper L. CD4+CD28- T cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality. Arthritis Rheum 2011, 63:2127-2137.
15. Hadrup S.R., Strindhall J., Kollgaard T., Seremet T., Johansson B., Pawelec G., thor Straten P., Wikby A. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006, 176:2645-2653.
16. Derhovanessian E., Larbi A., Pawelec G. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Curr Opin Immunol 2009, 21:440-445.
17. Lachmann R., Bajwa M., Vita S., Smith H., Cheek E., Akbar A., Kern F. Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses. J Virol 2012, 86:1001-1009.
18. Rafailidis P.I., Mourtzoukou E.G., Varbobitis I.C., Falagas M.E. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008, 5:47.
19. Wreghitt T.G., Teare E.L., Sule O., Devi R., Rice P. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 2003, 37:1603-1606.
20. Limaye A.P., Boeckh M. CMV in critically ill patients: pathogen or bystander?. Rev Med Virol 2010, 20:372-379.
21. Pass R.F., Zhang C., Evans A., Simpson T., Andrews W., Huang M.L., Corey L., Hill J., Davis E., Flanigan C., et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009, 360:1191-1199.
22. Sabbaj S., Pass R.F., Goepfert P.A., Pichon S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis 2011, 203:1534-1541.
23. Simanek A.M., Dowd J.B., Pawelec G., Melzer D., Dutta A., Aiello A.E. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 2011, 6:e16103.
24. Aiello A.E., Haan M., Blythe L., Moore K., Gonzalez J.M., Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 2006, 54:1046-1054.
25. Wikby A., Ferguson F., Forsey R., Thompson J., Strindhall J., Lofgren S., Nilsson B.O., Ernerudh J., Pawelec G., Johansson B. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A 2005, 60:556-565.
26. Derhovanessian E., Maier A.B., Hahnel K., Beck R., de Craen A.J., Slagboom E.P., Westendorp R.G., Pawelec G. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 2012, 92:2746-2756.
27. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Aging Dev 2007, 128:92-105.
28. Macaulay R., Akbar A.N., Henson S.M. The role of the T cell in age-related inflammation. Age (Dordr) 2012, January 15 (Epub ahead of print).
29. McElhaney J.E., Zhou X., Talbot H.K., Soethout E., Bleackley R.C., Granville D.J., Pawelec G. The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012, 30:2060-2067.
30. Strandberg T.E., Pitkala K.H., Tilvis R.S. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. J Am Med Assoc 2009, 301:380-382.
31. Stowe R.P., Kozlova E.V., Yetman D.L., Walling D.M., Goodwin J.S., Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 2007, 42:563-570.
32. Wang D., Li F., Freed D.C., Finnefrock A.C., Tang A., Grimes S.N., Casimiro D.R., Fu T.M. Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection. Vaccine 2011, 29:9075-9080.
33. Ross S.A., Arora N., Novak Z., Fowler K.B., Britt W.J., Boppana S.B. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010, 201:386-389.
34. Wang G.C., Kao W.H., Murakami P., Xue Q.L., Chiou R.B., Detrick B., McDyer J.F., Semba R.D., Casolaro V., Walston J.D., et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 2010, 171:1144-1152.
35. Roberts E.T., Haan M.N., Dowd J.B., Aiello A.E. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010, 172:363-371.
36. Moro-Garcia M.A., Alonso-Arias R., Lopez-Vazquez A., Suarez-Garcia F.M., Solano-Jaurrieta J.J., Baltar J., Lopez-Larrea C. Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age 2012, 34:479-495.
37. Mathei C., Vaes B., Wallemacq P., Degryse J. Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J Am Geriatr Soc 2011, 59:2201-2208.
38. Trzonkowski P., Mysliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., Machala M., Mysliwski A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003, 21:3826-3836.
39. den Elzen W.P., Vossen A.C., Cools H.J., Westendorp R.G., Kroes A.C., Gussekloo J. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 2011, 29:4869-4874.
40. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176:6333-6339.
41. McElhaney J.E., Ewen C., Zhou X., Kane K.P., Xie D., Hager W.D., Barry M.B., Kleppinger A., Wang Y., Bleackley R.C. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009, 27:2418-2425.
42. Wilkinson T.M., Li C.K., Chui C.S., Huang A.K., Perkins M., Liebner J.C., Lambkin-Williams R., Gilbert A., Oxford J., Nicholas B., et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012, 18:274-280.
43. Zhou X., McElhaney J.E. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011, 29:2169-2177.
44. Barton E.S., White D.W., Cathelyn J.S., Brett-McClellan K.A., Engle M., Diamond M.S., Miller V.L., Virgin H.W. Herpesevirus latency confers symbiotic protection from bacterial infection. Nature 2007, 447:326-329.
45. Kuningas M., May L., Tamm R., van Bodegom D., van den Biggelaar A.H., Meij J.J., Frölich M., Ziem J.B., Suchiman H.E., Metspalu A., et al. Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population. PLoS One 2009, 4:e7795.